Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: A prospective trial

British Journal of Cancer

Volumn 101, Issue 7, 2009, Pages 1066-1073

  Ferrandina, G ^a   Sallustio, G ^a   Fagotti, A ^b   Vizzielli, G ^b   Paglia, A ^a   Cucci, E ^a   Margariti, A ^b   Aquilani, L ^a   Garganese, G ^b   Scambia, G ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

CT scan; Cytoreduction; Ovarian cancer; Predictive models; Prospective trial

Indexed keywords

ACCURACY; AGED; ARTICLE; ASCITES; CANCER SURGERY; CELL ASSAY; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOREDUCTION; FEMALE; HUMAN; HYDROURETER; LAPAROTOMY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MESENTERY; OMENTUM; OVARY CANCER; PARAAORTIC LYMPH NODE; PERITONEUM CANCER; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70349658280     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605292     Document Type: Article

References (31)

1. Aletti GD, Dowdy JL, Podratz KL, Cliby WA (2007) Relationship among surgical complexity, short-term morbidity and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol 197: 676.e1-676.e7
2. Axtell AE, Lee MH, Bristow RE, Dowdy SC, Cliby WA, Raman S, Weaver JP, Gabbay M, Ngo M, Lentz S, Cass I, Li AJ, Karlan BY, Holschneider CH (2007) Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer. J Clin Oncol 25: 384-389 (Pubitemid 350002986)
3. Bristow RE, Duska LR, Lambrou NC, Fishman EK (2000) A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 89: 1532-1540
4. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20: 1248-1259
5. Brun JL, Rouzier R, Uzan S, Daraï E (2008) External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score. Gynecol Oncol 110: 354-359
6. Byrom J, Widjaja E, Redman CWE, Jones PW, Tebby S (2002) Can preoperative computer tomography predict resectabiity of ovarian carcinoma at primary laparotomy? Br J Obstet Gynecol 109: 369-375
7. Chi DS, Venkatraman ES, Masson V, Hoskins WJ (2000) The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma. Gynecol Oncol 77: 227-231 (Pubitemid 30317140)
8. Chi DS, Zivanovic O, Palayekar MJ, Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Leitao MM, Brown CL, Barakat RR (2009) A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma. Gynecol Oncol 112: 6-10
9. Cooper BC, Sood AK, Davis CS, Ritchie JM, Sorosky JL, Anderson B, Buller RE (2002) Preoperative CA-125 levels: an independent prognostic factor for epithelial ovarian cancer. Obstet Gynecol 100: 59-64 (Pubitemid 34722843)
10. Cox DR (1970) Analysis of Binary Data. Methven: London
11. Deeks JJ, Altman DG (2004) Diagnostic tests 4: likelihood ratios. Br Med J 329: 168-169
12. Dowdy SC, Mullany SA, Brandt KR, Huppert B, Cliby WA (2004) The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer 101: 346-352 (Pubitemid 38890839)
13. Eisenkop SM, Spirtos NM (2001) What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer? Gynecol Oncol 82: 489-497
14. Eisenkop SM, Spirtos NM, Lin WCM (2006) 'Optimal' cytoreduction for advanced epithelial ovarian cancer: a commentary. Gynecol Oncol 103: 329-335
15. Fagotti A, Ferrandina G, Fanfani F, Garganese G, Vizzielli G, Carone V, Salerno MG, Scambia G (2008) Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. Am J Obstet Gynecol 199: 642.e1-642.e6
16. Fagotti A, Ferrandina MG, Fanfani F, Ercoli A, Lorusso D, Rossi M, Scambia G (2006) A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. Ann Surg Oncol 13: 1156-1161 (Pubitemid 44337976)
17. Fanfani F, Ferrandina G, Corrado G, Fagotti A, Zakut HV, Mancuso S, Scambia G (2003) Impact of interval debulking surgery on clinical outcome in primary unresectable FIGO Stage IIIC ovarian cancer patients. Oncology 65: 16-22 (Pubitemid 38064943)
18. Forstner R, Hricak H, Occhipinti KA, Powell CB, Frankel SD, Stern JL (1995) Ovarian cancer: staging with CT and MR imaging. Radiology 197: 619-626
19. Gemer O, Gdalevich M, Ravid M, Piura B, Rabnovich A, Gasper T, Khashper A, Voldarsky M, Linov L, Ben Shacar I, Anteby EY, Lavie O (2009) A multicenter validation of computerized tomography models as predictors of non-optimal primary cytoreduction of advanced epithelial ovarian cancer. Eur J Surgical Oncol 1-4
20. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristics (ROC) curve. Radiology 143: 29-36
21. Hunter RW, Alexander ND, Soutter WP (1992) Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis? Am J Obstet Gynecol 166: 504-511
22. Memarzadeh S, Lee SB, Berek JS, Farias-Esner R (2003) CA-125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer. Int J Gynecol Cancer 13: 120-124 (Pubitemid 37055464)
23. Meyer JI, Kennedy AW, Friedman R, Hricak H, Occhipinti KA, Bethan Powell C, Frankel SD, Stern JL (1995) Ovarian carcinoma: value of CT in predicting success of debulking surgery. Am J Roentgenol 165: 875-878
24. Nelson BE, Rosenfield AT, Schwartz PE (1993) Preoperative abdomino-pelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol 11: 166-172
25. Nickles Fader A, Rose P (2007) Role of surgery in ovarian carcinoma. J Clin Oncol 25: 2873-2883
26. Qayyum A, Coakley FV, Westphalan AC, Hricak H, Okuno WT, Powell B (2005) Role of CT and MRI imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gynecol Oncol 96: 301-306 (Pubitemid 40127125)
27. Risum S, Høgdall C, Loft A, Berthelsen AK, Høgdall E, Nedergaard L, Lundvall L, Engelholm SA (2008) Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography-a prospective study. Gynecol Oncol 8: 265-270 (Pubitemid 351181445)
28. Saygili U, Guclu S, Uslu T, Erten O, Dogan E (2002) Can serum CA-125 levels predict the optimal primary cytoreduction in patients with advanced ovarian carcinoma? Gynecol Oncol 86: 57-61
29. Vergote I, Trope' CG, Amant F, Kristensen GB, Sardi JE, Ehelen T, Jonhson N, Verheijen RHM, Van der Burg MEL, Lacave AJ, Benedetti Panici P, Kenter GG, Casado A, Mendiola C, Coens C, Stuart G, Pecorelli S, Reed NS (2008) EORTC-GCG/NCIC-CTG randomized trial comparing primary debulking surgery with neoadjuvant chemotherapy in stage IIIC-IV ovarian, fallopian tube and peritoneal cancer. Biennial International Gynecological Cancer Society Meeting; Bangkok, 25-28 October
30. Vergote I, van Gorp T, Amant F, Neven P, Barteloot P (2005) Neoadjuvant chemotherapy for ovarian cancer. Oncology 19: 1615-1622
31. Wakabayashi MT, Lin PS, Hakim AA (2008) The role of cytoreductive/ debulking surgery in ovarian cancer. J Natl Compr Cancer Network 6: 803-810